Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.

Schildkraut, Joellen M

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. [electronic resource] - Journal of the National Cancer Institute Jan 2002 - 32-8 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0027-8874

10.1093/jnci/94.1.32 doi


Adult
Contraceptives, Oral, Hormonal--pharmacology
Estrogens--administration & dosage
Female
Humans
Logistic Models
Middle Aged
Ovarian Neoplasms--epidemiology
Progestins--administration & dosage
Risk